Comparative Effectiveness and Safety of <scp>PI‐Rd</scp> Triplets in Relapsed/Refractory Multiple Myeloma: <scp>INSIGHT‐MM</scp> Data Analysis

Authors

Institutions

Publication Details

Journal
European Journal Of Haematology
Published
2026-01-13
DOI
https://doi.org/10.1111/ejh.70079
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparative Effectiveness and Safety of PI‐Rd Triplets in Relapsed/Refractory Multiple Myeloma: INSIGHT‐MM Data Analysis

Hans Chulhee Lee, Isabel Nascimento-Ferreira, D. Cherepanov, Argiris Symeonidis et al.
European Journal Of Haematology
Multiple Myeloma Research and Treatments
article

Comparative Effectiveness and Safety of PI‐Rd Triplets in Relapsed/Refractory Multiple Myeloma: INSIGHT‐MM Data Analysis

Hans Chulhee Lee, Isabel Nascimento-Ferreira, D. Cherepanov, Argiris Symeonidis, Xavier P. Leleu, Faith E. Davies, Michael A. Thompson, K. Ren, Jesús G. Berdeja, R Hajek, G Cook, Jorge Vela Ojeda, Noemí Puig, Saad Z Usmani, Evangelos Terpos, Vania Hungria, Lenka Mokrá, David Arthur, Katja C Weisel
article en

Abstract

No abstract available for this paper.
European Journal Of HaematologyVol. 116(4)
University of Leeds (GB), Memorial Sloan Kettering Cancer Center (US), The University of Texas MD Anderson Cancer Center (US), University of Patras (GR), Universidad de Salamanca (ES), University of Ostrava (CZ), National and Kapodistrian University of Athens (GR), Eppendorf (Germany) (DE), General University Hospital of Patras (GR), Takeda (Switzerland) (CH), NYU Langone Health (US), University Hospital Ostrava (CZ), Patras Olympian Hospital (GR), Centre Hospitalier Universitaire de Poitiers (FR), São Germano Oncologia (BR), Tempus Labs (United States) (US), Institute of Health Information and Statistics (CZ), Tennessee Oncology (US), Takeda (United States) (US), Instituto Politécnico Nacional (MX)
Amgen, Bristol-Myers Squibb, Pfizer, AstraZeneca, GlaxoSmithKline, Sanofi, Alexion Pharmaceuticals, Celgene, Takeda Pharmaceuticals U.S.A., Regeneron Pharmaceuticals, BeiGene, Moderna, EUSA Pharma, Genentech, Kite Pharma, Juno Therapeutics
Good health and well-being
Openalex Percentile: Top 90%
Multiple Myeloma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.